
122 Labs is a technology company focused on increasing human life expectancy and improving the aging process through advancements in cognition, mobility, and vitality. Their mission is to make living to 122 years old commonplace by providing doctors with tools that enhance the prevention, diagnosis, and treatment of geriatric diseases. The company utilizes artificial intelligence and machine learning through its 122 Ecosystem™ to analyze past medical studies and patient data, aiming to find correlations between health results and longevity. Their product suite includes the Life Ecosystem™ for health monitoring, the Rehabilitation Circle for elderly rehabilitation, and various medical devices. They also offer a unique, free franchise concept for rehabilitation specialists, aiming to expand access to their technologies globally.

122 Labs is a technology company focused on increasing human life expectancy and improving the aging process through advancements in cognition, mobility, and vitality. Their mission is to make living to 122 years old commonplace by providing doctors with tools that enhance the prevention, diagnosis, and treatment of geriatric diseases. The company utilizes artificial intelligence and machine learning through its 122 Ecosystem™ to analyze past medical studies and patient data, aiming to find correlations between health results and longevity. Their product suite includes the Life Ecosystem™ for health monitoring, the Rehabilitation Circle for elderly rehabilitation, and various medical devices. They also offer a unique, free franchise concept for rehabilitation specialists, aiming to expand access to their technologies globally.
Focus: Longevity and geriatric health technology (cognition, mobility, vitality)
Core product: 122 Ecosystem™ (AI/ML analysis), Life Ecosystem™ monitoring devices and apps, Rehabilitation Circle
Founded: 2019
Headquarters: Warsaw, Poland
Notable investors: IVE Outdoor; Mateusz Lendzioszek
Longevity, geriatrics, gerontology, elderly rehabilitation and health monitoring
2019
Biotechnology
250000
800000
200000
“IVE Outdoor; Mateusz Lendzioszek”